As of 2025-07-04, the Relative Valuation of EyePoint Pharmaceuticals Inc (EYPT) is (41.17) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.72 USD, the upside of EyePoint Pharmaceuticals Inc based on Relative Valuation is -523.6%.
The range of the Relative Valuation is (41.00) - (39.38) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.4x - 18.5x | 18.0x |
| Forward P/E multiples | 19.2x - 22.3x | 20.6x |
| Fair Price | (41.00) - (39.38) | (41.17) |
| Upside | -521.8% - -505.1% | -523.6% |
| Date | P/E |
| 2025-07-01 | -4.27 |
| 2025-06-30 | -4.41 |
| 2025-06-27 | -4.52 |
| 2025-06-26 | -4.86 |
| 2025-06-25 | -4.94 |
| 2025-06-24 | -4.30 |
| 2025-06-23 | -3.88 |
| 2025-06-20 | -3.95 |
| 2025-06-18 | -4.18 |
| 2025-06-17 | -4.13 |
| 2025-06-16 | -4.17 |
| 2025-06-13 | -4.23 |
| 2025-06-12 | -4.15 |
| 2025-06-11 | -4.13 |
| 2025-06-10 | -4.32 |
| 2025-06-09 | -4.19 |
| 2025-06-06 | -4.19 |
| 2025-06-05 | -3.87 |
| 2025-06-04 | -3.84 |
| 2025-06-03 | -3.81 |
| 2025-06-02 | -3.48 |
| 2025-05-30 | -3.39 |
| 2025-05-29 | -3.38 |
| 2025-05-28 | -3.30 |
| 2025-05-27 | -2.79 |
| 2025-05-23 | -2.66 |
| 2025-05-22 | -2.63 |
| 2025-05-21 | -2.75 |
| 2025-05-20 | -2.91 |
| 2025-05-19 | -2.86 |
| 2025-05-16 | -2.87 |
| 2025-05-15 | -2.68 |
| 2025-05-14 | -2.57 |
| 2025-05-13 | -2.77 |
| 2025-05-12 | -2.74 |
| 2025-05-09 | -2.72 |
| 2025-05-08 | -2.86 |
| 2025-05-07 | -2.85 |
| 2025-05-06 | -2.93 |
| 2025-05-05 | -3.22 |
| 2025-05-02 | -3.42 |
| 2025-05-01 | -3.34 |
| 2025-04-30 | -3.20 |
| 2025-04-29 | -3.11 |
| 2025-04-28 | -3.18 |
| 2025-04-25 | -2.99 |
| 2025-04-24 | -3.07 |
| 2025-04-23 | -3.15 |
| 2025-04-22 | -3.05 |
| 2025-04-21 | -2.77 |